Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;26(1):78-85.
doi: 10.1097/CCO.0000000000000024.

To be, or not to be: functional dilemma of p53 metabolic regulation

Shang-Jui Wang  1 , Wei Gu
Affiliations
Review

To be, or not to be: functional dilemma of p53 metabolic regulation

Shang-Jui Wang et al. Curr Opin Oncol. 2014 Jan.

Abstract

Purpose of review: In recent years, the emerging role of p53 in metabolic regulation has been a topic of great interest. Although apoptotic and growth arrest functions of p53 remain as important mechanisms for preserving genomic stability, metabolic functions of p53 show increasing potential in contributing to p53-mediated tumor suppression. Numerous recent studies provided further insights into the metabolic functions of p53 and their implications in tumorigenesis.

Recent findings: Several novel p53 metabolic targets have been identified that participate in various aspects of metabolism. Although some studies demonstrate the potential tumor suppressive function of p53 metabolic genes, others reveal prosurvival roles of those targets in both tumor and normal cells. Specifically, Tp53-induced glycolysis and apoptosis regulator (TIGAR) has been thought to promote tumor suppression through metabolic fine-tuning, yet, TIGAR-deficient mice display reduction in tumorigenesis. Finally, characterization of the 3KR mouse model underscored the significance of p53 metabolic regulation in tumor suppression, while also alluding to the potential mechanism for selective regulation of p53 metabolic targets.

Summary: Expression of many p53 metabolic genes elicits both antitumor and tumorigenic effects, suggesting that p53 may contribute to cellular protection as well as tumor suppression. Future studies must carefully dissect the duality of p53 metabolic function, which may potentially prove useful in designing cancer therapies.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Figures

Figure 1
Figure 1. p53 exerts a diverse array of metabolic functions
A broad spectrum of metabolic targets are regulated by p53, leading to various functional outcomes in tumor and normal physiology. Genes in blue boxes are previously-identified p53 targets, while those in green boxes are most recently discovered. Dashed line in the GLS2 axis illustrates the potential of this target in enhancing tumor survival based on its function. Abbr. OXPHOS, oxidative phosphorylation; S1P, sphingosine-1-phosphate; FAO, fatty acid oxidation; CoA, coenzyme A.
Figure 2
Figure 2. Opposing functions of p53 metabolic regulation
Metabolic regulation by p53 in tumorigenesis is a double-edged sword: maintaining oxidative balance and energy homeostasis could prevent cancer development in the pre-cancerous stage, but favors tumor survival after malignant transformation.
Figure 3
Figure 3. A hypothetical model of differential regulation by p53
p53 is subjected to a hierarchical sequence of post-translational modifications as stress level increases, which induces various functional outcome depending on the combination of modifications (see text for complete description).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lane DP. Cancer. p53, guardian of the genome. Nature. 1992;358:15–16. - PubMed
    1. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature. 2000;408:307–310. - PubMed
    1. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell. 2009;137:413–431. - PubMed
    1. Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9:749–758. - PMC - PubMed
    1. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323–331. - PubMed

Publication types

Substances